Yongchao Su

Yongchao Su serves as Adjunct Associate Professor in Molecular Pharmaceutics and Drug Delivery at the University of Texas at Austin while holding a Senior Principal Scientist position at Merck & Co., Inc. His dual roles bridge academic research and industrial pharmaceutical development with over a decade of specialized experience.

Education:

• Ph.D. in Structural Biophysics, Iowa State University (2006–2011)
• Postdoctoral Training, Department of Chemistry, MIT (2011–2014)

Dr. Su's research centers on molecular mechanisms of drug delivery and stability, driving innovation in therapeutic design. His expertise spans candidate selection through analytical development for chemical and biological products, with significant contributions to high-concentration formulations like pembrolizumab suspensions. His work demonstrates strong translational impact between fundamental biophysics and clinical applications.

He maintains active editorial leadership as Editor-in-Chief of AAPS Open (Springer Nature) and serves on the Advisory Boards of Molecular Pharmaceutics, Pharmaceutical Research, and Journal of Pharmaceutical Sciences.